UK Loophole Allows Children to Access Puberty Blockers Despite Ban: Former PM Calls for Legal Change

The UK's National Health Service (NHS) recently banned the use of puberty blockers for children due to lack of evidence on safety and effectiveness.

These drugs prevent bodily changes during puberty and are often used by children unsure of their gender.

Despite the ban, some children may still access the drugs through a loophole, allowing them to continue receiving the treatment on taxpayers' money.

Puberty blockers limit the production of hormones that trigger puberty.

A report by Dr. Hilary Cass in 2022 raised concerns about the use of medications to prevent bodily changes in children unsure of their gender, citing "gaps in evidence." The report suggested a change in care strategy for those experiencing gender-related distress.

However, it does not plan to close a legal loophole that allows doctors to prescribe these medications under exceptional circumstances.

Former UK Prime Minister Liz Truss is advocating for the loophole's closure, fearing that children may not be adequately protected from exploitation.

A doctor is calling for a change in the law to stop the prescription of puberty blockers to children under 18 in both the private sector and the NHS.

She argues that non-statutory guidance and reviews are not sufficient to protect children from the harmful consequences of these treatments, which have no proven benefits.

Dr Louise Irvine, co-chair of the Clinical Advisory Network on Sex and Gender, agrees that the lack of evidence for benefits makes it impossible for medical professionals to justify the use of puberty blockers in exceptional circumstances.

Dr. Caroline Johnson, a Conservative MP and paediatrician, expressed concerns about the use of puberty blockers for children in the NHS, questioning the threshold of benefit and the understanding of risks.

Tory MP Nick Fletcher called the use of such drugs "abhorrent" and warned of potential psychological harm.

Dr. Cass's final report, set to be released, is expected to examine the use of cross-sex hormones and social transitioning among children in greater detail.

Advocates are pushing for Dr. Cass to make recommendations that protect 17-year-olds from being referred to adult gender clinics, where they could potentially receive prescriptions for cross-sex hormones.